Creative Capital Management Investments LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1957363
SAN DIEGO, CA
Position in NBIX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,202
New position
Shares Held
19
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#720
of 768 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Creative Capital Management Investments LLC holds $25,031 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
361 | $5,732 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
10 | $5,418 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
149 | $3,666 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
19 | $3,202 | |
| 5 | ALKS |
Alkermes plc.
|
37 | $1,938 | |
| 6 | ZTS |
Zoetis Inc.
|
21 | $1,509 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
12 | $1,331 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
45 | $778 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,202 | 19 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||